Research progress in Guanxin Tongluo capsule for the treatment of coronary heart disease / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
;
(12): 157-160, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-931586
ABSTRACT
Guanxin Tongluo capsule is a compound traditional Chinese medicine preparation for the treatment of coronary heart disease. The underlying mechanism may be related to expanding coronary artery, increasing coronary artery blood flow, reducing myocardial oxygen consumption, and decreasing whole blood viscosity, plasma viscosity, and hematocrit. This paper reviews the clinical research progress of Guanxin Tongluo capsule in the treatment of coronary heart disease from the aspects of etiology, pathogenesis, pharmacological research, and clinical research, providing evidence for scientific research and clinical application of Guanxin Tongluo capsule.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Primary Medicine and Pharmacy
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS